AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,242,846 | -7.8% | 50,216 | +5.5% | 0.00% | 0.0% |
| Q2 2023 | $1,348,145 | +24.8% | 47,604 | +1.3% | 0.00% | 0.0% |
| Q1 2023 | $1,079,912 | -29.3% | 47,014 | -14.8% | 0.00% | 0.0% |
| Q4 2022 | $1,526,875 | -2.8% | 55,153 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $1,570,531 | +26.7% | 55,196 | -0.7% | 0.00% | 0.0% |
| Q2 2022 | $1,239,285 | -22.8% | 55,586 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $1,605,053 | +71.5% | 54,863 | +94.8% | 0.00% | 0.0% |
| Q4 2021 | $936,000 | -33.9% | 28,161 | -8.2% | 0.00% | 0.0% |
| Q3 2021 | $1,416,000 | -26.2% | 30,686 | -11.9% | 0.00% | -50.0% |
| Q2 2021 | $1,919,000 | +1261.0% | 34,830 | +1972.0% | 0.00% | – |
| Q2 2018 | $141,000 | +3.7% | 1,681 | +0.8% | 0.00% | – |
| Q1 2018 | $136,000 | +60.0% | 1,668 | +12.5% | 0.00% | – |
| Q4 2017 | $85,000 | -13.3% | 1,483 | +1.2% | 0.00% | – |
| Q3 2017 | $98,000 | +66.1% | 1,465 | +28.4% | 0.00% | – |
| Q2 2017 | $59,000 | -6.3% | 1,141 | +6.5% | 0.00% | – |
| Q1 2017 | $63,000 | +40.0% | 1,071 | 0.0% | 0.00% | – |
| Q4 2016 | $45,000 | -19.6% | 1,071 | +1.6% | 0.00% | – |
| Q3 2016 | $56,000 | +27.3% | 1,054 | -0.6% | 0.00% | – |
| Q2 2016 | $44,000 | +10.0% | 1,060 | +0.6% | 0.00% | – |
| Q1 2016 | $40,000 | -41.2% | 1,054 | 0.0% | 0.00% | – |
| Q4 2015 | $68,000 | -8.1% | 1,054 | 0.0% | 0.00% | – |
| Q3 2015 | $74,000 | -37.3% | 1,054 | -0.9% | 0.00% | – |
| Q2 2015 | $118,000 | -87.5% | 1,064 | -89.4% | 0.00% | -100.0% |
| Q1 2015 | $945,000 | -9.7% | 10,021 | +7.2% | 0.00% | -50.0% |
| Q4 2014 | $1,047,000 | +82.7% | 9,350 | +0.1% | 0.00% | +100.0% |
| Q3 2014 | $573,000 | +35.8% | 9,345 | +1.6% | 0.00% | 0.0% |
| Q2 2014 | $422,000 | +79.6% | 9,195 | +53.0% | 0.00% | – |
| Q1 2014 | $235,000 | +80.8% | 6,011 | +10.3% | 0.00% | – |
| Q4 2013 | $130,000 | +2500.0% | 5,449 | +2861.4% | 0.00% | – |
| Q3 2013 | $5,000 | – | 184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |